Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H1 2018, provides an overview of the Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.
Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary modification.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Diabetic Nephropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 15, 13, 1, 30, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 6 and 2 molecules, respectively.
Diabetic Nephropathy (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note : Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Diabetic Nephropathy (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Diabetic Nephropathy (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Diabetic Nephropathy (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Diabetic Nephropathy (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Diabetic Nephropathy (Metabolic Disorders)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Diabetic Nephropathy (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Diabetic Nephropathy (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Diabetic Nephropathy - Pipeline Review, H1 2018
Table of Contents
Table of Contents 2
Introduction 5
Diabetic Nephropathy - Overview 6
Diabetic Nephropathy - Therapeutics Development 7
Diabetic Nephropathy - Therapeutics Assessment 18
Diabetic Nephropathy - Companies Involved in Therapeutics Development 28
Diabetic Nephropathy - Drug Profiles 48
Diabetic Nephropathy - Dormant Projects 209
Diabetic Nephropathy - Discontinued Products 212
Diabetic Nephropathy - Product Development Milestones 213
Appendix 223
List of Tables
Number of Products under Development for Diabetic Nephropathy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Diabetic Nephropathy - Pipeline by AbbVie Inc, H1 2018
Diabetic Nephropathy - Pipeline by Antisense Therapeutics Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Aptevo Therapeutics Inc, H1 2018
Diabetic Nephropathy - Pipeline by Araim Pharmaceuticals Inc, H1 2018
Diabetic Nephropathy - Pipeline by Astellas Pharma Inc, H1 2018
Diabetic Nephropathy - Pipeline by AstraZeneca Plc, H1 2018
Diabetic Nephropathy - Pipeline by Bayer AG, H1 2018
Diabetic Nephropathy - Pipeline by BLR Bio LLC, H1 2018
Diabetic Nephropathy - Pipeline by Boehringer Ingelheim GmbH, H1 2018
Diabetic Nephropathy - Pipeline by Cellmid Ltd, H1 2018
Diabetic Nephropathy - Pipeline by ChemoCentryx Inc, H1 2018
Diabetic Nephropathy - Pipeline by CSL Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Daiichi Sankyo Co Ltd, H1 2018
Diabetic Nephropathy - Pipeline by DiaMedica Therapeutics Inc, H1 2018
Diabetic Nephropathy - Pipeline by Dynamis Therapeutics Inc, H1 2018
Diabetic Nephropathy - Pipeline by Galectin Therapeutics Inc, H1 2018
Diabetic Nephropathy - Pipeline by GenKyoTex SA, H1 2018
Diabetic Nephropathy - Pipeline by Gilead Sciences Inc, H1 2018
Diabetic Nephropathy - Pipeline by GNI Group Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Inspyr Therapeutics Inc, H1 2018
Diabetic Nephropathy - Pipeline by Ironwood Pharmaceuticals Inc, H1 2018
Diabetic Nephropathy - Pipeline by Johnson & Johnson, H1 2018
Diabetic Nephropathy - Pipeline by MediPost Co Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Merck & Co Inc, H1 2018
Diabetic Nephropathy - Pipeline by Mesoblast Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2018
Diabetic Nephropathy - Pipeline by MorphoSys AG, H1 2018
Diabetic Nephropathy - Pipeline by Noxxon Pharma AG, H1 2018
Diabetic Nephropathy - Pipeline by Paranta Biosciences Ltd, H1 2018
Diabetic Nephropathy - Pipeline by PhiloGene Inc, H1 2018
Diabetic Nephropathy - Pipeline by PhytoHealth Corp, H1 2018
Diabetic Nephropathy - Pipeline by ProMetic Life Sciences Inc, H1 2018
Diabetic Nephropathy - Pipeline by Redx Pharma Plc, H1 2018
Diabetic Nephropathy - Pipeline by Regeneron Pharmaceuticals Inc, H1 2018
Diabetic Nephropathy - Pipeline by Sarfez Pharmaceuticals Inc, H1 2018
Diabetic Nephropathy - Pipeline by Serodus ASA, H1 2018
Diabetic Nephropathy - Pipeline by Teijin Pharma Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Theravance Biopharma Inc, H1 2018
Diabetic Nephropathy - Pipeline by Torrent Pharmaceuticals Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Twoxar Inc, H1 2018
Diabetic Nephropathy - Pipeline by Ube Industries Ltd, H1 2018
Diabetic Nephropathy - Pipeline by Vascular Pharmaceuticals Inc, H1 2018
Diabetic Nephropathy - Pipeline by Vicore Pharma AB, H1 2018
Diabetic Nephropathy - Dormant Projects, H1 2018
Diabetic Nephropathy - Dormant Projects, H1 2018 (Contd..1), H1 2018
Diabetic Nephropathy - Dormant Projects, H1 2018 (Contd..2), H1 2018
Diabetic Nephropathy - Discontinued Products, H1 2018
List of Figures
Number of Products under Development for Diabetic Nephropathy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Top 10 Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018
Global Hemodialysis Powder Solution Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Hemodialysis Powder Solution market was valued at US$ 392.9 million in 2023 and is anticipated to reach US$ 594.8 million by 2030, witnessing a CAGR of 6.6% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in re......
Global Hemodialysis Concentrates Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Hemodialysis Concentrates market size was valued at US$ 2408.5 million in 2023. With growing demand in downstream market, the Hemodialysis Concentrates is forecast to a readjusted size of US$ 3027 million by 2030 with a CAGR of 3.3% during review period.
The research report highlights the growth potential of the global Hemodialysis Concentrates market. Hemodialysis Concentrates are expected to show stable growth in the future......
Global Hemodialysis Concentrates Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 159
According to our (Global Info Research) latest study, the global Hemodialysis Concentrates market size was valued at USD 2533.3 million in 2023 and is forecast to a readjusted size of USD 3128.8 million by 2030 with a CAGR of 3.1% during review period.
Hemodialysis concentrates including:
Acid concentrates
A-concentrate
Acidified concentrated mixture of salts that, when diluted with dialysis water and bicarbonate concentrate, yields dialysis fluid for use in dialysis......
Hemodialysis Powder Solution - Global Market Insights and Sales Trends 2024
Published: 21-Dec-2023 Price: US 3350 Onwards Pages: 100
The global Hemodialysis Powder Solution market size is expected to reach US$ 594.8 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hemodialysis Powder Solution in various end use industries. The expanding demands from the Public Hospital, Private Clinic, Nursing Home and Personal Care, are propelling Hemodialysis Powder Solution market. Hemodialysis Concentrates, one of the segments analysed in this report, is projected......
Global Peritoneal Dialysis Solution Market Research Report 2023, Forecast to 2028
Published: 15-Dec-2023 Price: US 2680 Onwards Pages: 139
During peritoneal dialysis, a cleansing fluid (dialysate) is circulated through a tube (catheter) inside part of your abdominal cavity (peritoneal cavity). The dialysate absorbs waste products from blood vessels in your abdominal lining (peritoneum) and then is drawn back out of your body and discarded.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million U......
Global Peritoneal Dialysis Solution Professional Survey Report 2023, Forecast to 2028
Published: 15-Dec-2023 Price: US 3280 Onwards Pages: 100
During peritoneal dialysis, a cleansing fluid (dialysate) is circulated through a tube (catheter) inside part of your abdominal cavity (peritoneal cavity). The dialysate absorbs waste products from blood vessels in your abdominal lining (peritoneum) and then is drawn back out of your body and discarded.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million U......
Global Hemodialysis Concentrates Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 110
Market Overview of Global Hemodialysis Concentrates market:
According to our latest research, the global Hemodialysis Concentrates market looks promising in the next 5 years. As of 2022, the global Hemodialysis Concentrates market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Hemodialysis, also spelled haemodialysis, commonly called kidney dialysis or simply dialysis, is a process of purify......
Global Hemodialysis Powder Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 24-Oct-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Hemodialysis Powder Solution market:
According to our latest research, the global Hemodialysis Powder Solution market looks promising in the next 5 years. As of 2022, the global Hemodialysis Powder Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
Global Hemodialysis Powder Solution Market Research Report 2023
Published: 12-Oct-2023 Price: US 2900 Onwards Pages: 94
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hemodialysis Powder Solution market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Baxter
- Rockwell Medical
- Fresenius
- B. Braun
- Renacon Pharma
- Chief Medical Supplies
- Farmasol
- Weigao
- Tia......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
